Skip to main content

HOPA Abstracts

Optimization of Rasburicase Dose for the Management of Tumor Lysis Syndrome in Community Oncology Practices
Abstract #CR12
Read More
Pharmacist-Led 14-Day Oncolytic Drug Check-In Protocol
Abstract #CR13
Read More
Safety of Rapid Dose Escalation of Venetoclax in Patients with Hematologic Malignancies
Abstract #CR14
Read More
Safety Outcomes of Oxaliplatin Rapid-Rate Infusion versus Standard-Rate Infusion
Abstract #CR15
Read More
Strategies for Implementing an Oral Medication Adherence Intervention
Abstract #CR16
Read More
Effectiveness of High-Dose Intravenous Acyclovir in Preventing Cytomegalovirus Infection in Allogeneic Stem-Cell Transplantation Recipients: A Retrospective Study in a Medical Center in Singapore
Abstract #CR17
Read More
Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with Extensive-Stage Small-Cell Lung Cancer in US Community Oncology Settings
Abstract #CR18
Read More
Urinary Tract Infections in Patients Receiving Chemotherapy and SGLT2 Inhibitors
Abstract #CR19
Read More
Use of Ursodiol for SOS/VOD Prophylaxis in Patients with Acute Leukemia Receiving Gemtuzumab-Ozogamicin or Inotuzumab-Ozogamicin
Abstract #CR20
Read More
Use of Bevacizumab Originator versus Biosimilar Drugs for Oncology Indications in a Real-World Data Sample
Abstract #CR21
Read More
Page 7 of 12
Results 61 - 70 of 119